<!DOCTYPE html>
<html lang="en-us"
  dir="ltr">

<head>
  <meta charset="utf-8">
<meta name="viewport" content="width=device-width">



<link rel="icon" type="image/ico" href="https://reports.muthu.co/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://reports.muthu.co/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://reports.muthu.co/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="192x192" href="https://reports.muthu.co/android-chrome-192x192.png">
<link rel="apple-touch-icon" sizes="180x180" href="https://reports.muthu.co/apple-touch-icon.png">

<meta name="description" content=""/>



<title>
    
    GMM Pfaudler Ltd - Feb 2025 Earnings Call Transcript Analysis | Financial Report Insights
    
</title>
<link href="/pagefind/pagefind-ui.css" rel="stylesheet">
<script src="/pagefind/pagefind-ui.js"></script>
<link rel="canonical" href="https://reports.muthu.co/posts/gmm-pfaudler-ltd---feb-2025-earnings-call-transcript-analysis/"/>

<meta property="og:url" content="https://reports.muthu.co/posts/gmm-pfaudler-ltd---feb-2025-earnings-call-transcript-analysis/">
  <meta property="og:site_name" content="Financial Report Insights">
  <meta property="og:title" content="GMM Pfaudler Ltd - Feb 2025 Earnings Call Transcript Analysis">
  <meta property="og:description" content="Earnings Call Transcript Analysis Report # Financial Performance # Key Financial Metrics # Revenue (Q3 FY25): INR 801 crores (stable compared to the previous quarter). EBITDA (Q3 FY25): Up 3% compared to the previous quarter. EBITDA Margins (Q3 FY25): 12% (improved from 11.6% in the previous quarter). Order Intake (Q3 FY25): INR 798 crore (up 5% compared to the previous quarter). Order Intake (9M FY25): Up 13% compared to the previous nine months. Order Backlog (as of Dec 31, 2024): INR 1740 crore (up 7% compared to December 31, 2023). Standalone Business (India - YoY): Revenue down 8% (YoY for the quarter). Standalone Services Revenue (India): Showed strong uptake. Other Income (Q3 FY25 Consolidated): INR 25 crores, primarily due to FX gain. Net Debt Cost: Less than 8% (India and international combined). Comparison with Previous Periods # Revenue: Stable Q-o-Q. EBITDA &amp; Margins: Improved Q-o-Q. Order Intake: Up Q-o-Q (5%) and 9M Y-o-Y (13%). Order Backlog: Up Y-o-Y (7%). Standalone India business revenue: Down 8% Y-o-Y for the quarter. Revised Guidance or Forecasts # Management aims for 15% margin profile across businesses in the long run. Expects to finish the current year with EBITDA margins around 11-12%. Hopes to improve margins in the next financial year but finds it “premature” to give a specific number. Areas of Growth or Decline # Growth: Non-GLE business (mixing, heavy engineering, solid-liquid separation). Services business in India. Heavy engineering business. Decline/Slowdown: GLE business (starting to recover). Chemical industry, especially agrochemicals. International business (showing a slowdown). Strategic Initiatives &amp; Business Updates # Major Strategic Announcements # Diversification: Reducing focus on chemicals and pharma, exploring new industry segments (oil &amp; gas, petrochemicals, metals &amp; minerals, semiconductors). Cost Structure Rationalization: Consolidation of glass-lined capacity in Europe and India. Moved all India GLE production to the Gujarat facility from Hyderabad. Rationalized UK manufacturing footprint. Poland Strategy: Moving manufacturing to Poland and potentially India. McKinsey project ongoing in India for operational cost reduction. Focus on Services: Growing the services business in India. New Products, Services, or Markets Discussed # New Markets/Segments: Oil &amp; gas, petrochemicals, metals &amp; minerals, wastewater, paints, semiconductors. Services: Increased focus and organizational changes to grow this segment in India. Mixing Business: A key area of focus. Heavy Engineering: Focus on right MOCs, export orders, and specific equipment. Biological Space: Keeping track of developments and engaged with customers on peptides. Significant Operational Changes # Hyderabad Facility: Production consolidated to Gujarat. Facility “on hold”. UK Manufacturing: Footprint rationalized. Poland Manufacturing: Investment agreement signed, initial orders successfully executed. Ongoing or Completed Projects # Poland Facility Development: Ongoing. McKinsey Cost Optimization Project (India): At the final stage. Test Center (Karamsad, Gujarat): Inaugurated and operational. Market &amp; Competitive Landscape # Industry Trends # Chemical Industry: Generally slow, driven by agrochemical slowdown. Specialty Chemicals: Expected to continue to grow and invest. Pharmaceutical Industry: Generally positive, traction in South India (Hyderabad) for CDMO/export capacity. Cyclicality: Acknowledged in chemical and pharma markets, driving diversification. Manufacturing returning to the US: Mentioned as a potential driver for heavy engineering exports. Competitive Positioning Statements # GLE in India: Do not see significant Chinese competition. Non-GLE: Occasional competition from China and other countries, but GMM Pfaudler is well-positioned. Differentiation: Aims for technical differentiation in every product line. Brand Reputation: GMM Pfaudler brand associated with problem-solving. Market Challenges or Opportunities Mentioned # Challenges: Slowdown in chemical (especially agrochemical) and pharmaceutical industries. International business slowdown, particularly Europe. Cyclical nature of core markets. Opportunities: Diversification into new industries. Growth in the services business in India. Export potential for heavy engineering. Cost efficiencies from manufacturing footprint rationalization. Market recovery in chemicals/pharma expected in a few quarters. Comments about Market Share or Positioning # GLE: Market share is 50%. New Industries: Market share is “very, very small”. Market Leader in Hyderabad (GLE). Risk Factors &amp; Challenges # Concerns or Challenges Acknowledged by Management # Slowdown in Core Markets: Chemical (agrochemical) and pharmaceutical industry slowdown. Cyclicality of Markets: Over-reliance on chemical and pharma markets. International Business Slowdown: Europe, in particular, is experiencing a slowdown. Time for Recovery: Full turnaround in chemical and pharmaceutical industries might take “a few more quarters.” Execution of Diversification: Finding new opportunities in non-GLE and non-chemical/pharma industries takes time. Download Transcript">
  <meta property="og:locale" content="en_us">
  <meta property="og:type" content="article">
    <meta property="article:section" content="posts">
    <meta property="article:published_time" content="2025-02-13T18:50:04+00:00">
    <meta property="article:modified_time" content="2025-02-13T18:50:04+00:00">
    <meta property="article:tag" content="GMM Pfaudler Ltd.">
    <meta property="article:tag" content="GMMPFAUDLR">
    <meta property="article:tag" content="Industrial Machinery">
    <meta property="article:tag" content="Industrials">
    <meta property="article:tag" content="Small Cap">
    <meta property="article:tag" content="Earnings Call">













<link rel="stylesheet" href="/assets/combined.min.722a154090e948dfc0b4cf97263194700c53c73fc095c249b60a5c9caddbbf84.css" media="all">




      <script async src="https://www.googletagmanager.com/gtag/js?id=G-T7PH4WNH24"></script>
      <script>
        var doNotTrack = false;
        if ( false ) {
          var dnt = (navigator.doNotTrack || window.doNotTrack || navigator.msDoNotTrack);
          var doNotTrack = (dnt == "1" || dnt == "yes");
        }
        if (!doNotTrack) {
          window.dataLayer = window.dataLayer || [];
          function gtag(){dataLayer.push(arguments);}
          gtag('js', new Date());
          gtag('config', 'G-T7PH4WNH24');
        }
      </script>




<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-3609399560636561" crossorigin="anonymous"></script>
</head>







<body class="light">
  <div class="content">
    <header>
      

<div class="header">

    
    <div id="search"></div>
</div>

    </header>
    <main class="main">
      





<div class="breadcrumbs">
    
    <a href="/">Home</a>
    <span class="breadcrumbs-separator"> > </span>
    
    <a href="/posts/">Posts</a>
    <span class="breadcrumbs-separator"> > </span>
    
    <a class="breadcrumbs-current" href="/posts/gmm-pfaudler-ltd---feb-2025-earnings-call-transcript-analysis/">GMM Pfaudler Ltd - Feb 2025 Earnings Call Transcript Analysis</a>
</div>



<div >

  <div class="single-intro-container">

    

    <h1 class="single-title" data-pagefind-body>GMM Pfaudler Ltd - Feb 2025 Earnings Call Transcript Analysis</h1>
    

    

    <p class="single-readtime">
      
      
      
      <time datetime="2025-02-13T18:50:04&#43;00:00">February 13, 2025</time>
      

      
      &nbsp; · &nbsp;
      4 min read
      
    </p>

  </div>

  

  
  

  <div class="single-tags">
    
    <span>
      <a href="https://reports.muthu.co/tags/gmm-pfaudler-ltd./">#GMM Pfaudler Ltd.</a>
    </span>
    
    
    <span>
      <a href="https://reports.muthu.co/tags/gmmpfaudlr/">#GMMPFAUDLR</a>
    </span>
    
    
    <span>
      <a href="https://reports.muthu.co/tags/industrial-machinery/">#Industrial Machinery</a>
    </span>
    
    
    <span>
      <a href="https://reports.muthu.co/tags/industrials/">#Industrials</a>
    </span>
    
    
    <span>
      <a href="https://reports.muthu.co/tags/small-cap/">#Small Cap</a>
    </span>
    
    
    <span>
      <a href="https://reports.muthu.co/tags/earnings-call/">#Earnings Call</a>
    </span>
    
    
  </div>

  
  

  

  
  <aside class="toc">
    <p><strong>Table of contents</strong></p>
    <nav id="TableOfContents">
  <ul>
    <li><a href="#earnings-call-transcript-analysis-report">Earnings Call Transcript Analysis Report</a></li>
    <li><a href="#financial-performance">Financial Performance</a>
      <ul>
        <li><a href="#key-financial-metrics">Key Financial Metrics</a></li>
        <li><a href="#comparison-with-previous-periods">Comparison with Previous Periods</a></li>
        <li><a href="#revised-guidance-or-forecasts">Revised Guidance or Forecasts</a></li>
        <li><a href="#areas-of-growth-or-decline">Areas of Growth or Decline</a></li>
      </ul>
    </li>
    <li><a href="#strategic-initiatives--business-updates">Strategic Initiatives &amp; Business Updates</a>
      <ul>
        <li><a href="#major-strategic-announcements">Major Strategic Announcements</a></li>
        <li><a href="#new-products-services-or-markets-discussed">New Products, Services, or Markets Discussed</a></li>
        <li><a href="#significant-operational-changes">Significant Operational Changes</a></li>
        <li><a href="#ongoing-or-completed-projects">Ongoing or Completed Projects</a></li>
      </ul>
    </li>
    <li><a href="#market--competitive-landscape">Market &amp; Competitive Landscape</a>
      <ul>
        <li><a href="#industry-trends">Industry Trends</a></li>
        <li><a href="#competitive-positioning-statements">Competitive Positioning Statements</a></li>
        <li><a href="#market-challenges-or-opportunities-mentioned">Market Challenges or Opportunities Mentioned</a></li>
        <li><a href="#comments-about-market-share-or-positioning">Comments about Market Share or Positioning</a></li>
      </ul>
    </li>
    <li><a href="#risk-factors--challenges">Risk Factors &amp; Challenges</a>
      <ul>
        <li><a href="#concerns-or-challenges-acknowledged-by-management">Concerns or Challenges Acknowledged by Management</a></li>
      </ul>
    </li>
  </ul>
</nav>
  </aside>
  

  

  <div class="single-content">
    <h2 class="heading" id="earnings-call-transcript-analysis-report">
  Earnings Call Transcript Analysis Report
  <a class="anchor" href="#earnings-call-transcript-analysis-report">#</a>
</h2>
<h2 class="heading" id="financial-performance">
  Financial Performance
  <a class="anchor" href="#financial-performance">#</a>
</h2>
<h3 class="heading" id="key-financial-metrics">
  Key Financial Metrics
  <a class="anchor" href="#key-financial-metrics">#</a>
</h3>
<ul>
<li><strong>Revenue (Q3 FY25):</strong> INR 801 crores (stable compared to the previous quarter).</li>
<li><strong>EBITDA (Q3 FY25):</strong> Up 3% compared to the previous quarter.</li>
<li><strong>EBITDA Margins (Q3 FY25):</strong> 12% (improved from 11.6% in the previous quarter).</li>
<li><strong>Order Intake (Q3 FY25):</strong> INR 798 crore (up 5% compared to the previous quarter).</li>
<li><strong>Order Intake (9M FY25):</strong> Up 13% compared to the previous nine months.</li>
<li><strong>Order Backlog (as of Dec 31, 2024):</strong> INR 1740 crore (up 7% compared to December 31, 2023).</li>
<li><strong>Standalone Business (India - YoY):</strong> Revenue down 8% (YoY for the quarter).</li>
<li><strong>Standalone Services Revenue (India):</strong> Showed strong uptake.</li>
<li><strong>Other Income (Q3 FY25 Consolidated):</strong> INR 25 crores, primarily due to FX gain.</li>
<li><strong>Net Debt Cost:</strong> Less than 8% (India and international combined).</li>
</ul>
<h3 class="heading" id="comparison-with-previous-periods">
  Comparison with Previous Periods
  <a class="anchor" href="#comparison-with-previous-periods">#</a>
</h3>
<ul>
<li>Revenue: Stable Q-o-Q.</li>
<li>EBITDA &amp; Margins: Improved Q-o-Q.</li>
<li>Order Intake: Up Q-o-Q (5%) and 9M Y-o-Y (13%).</li>
<li>Order Backlog: Up Y-o-Y (7%).</li>
<li>Standalone India business revenue: Down 8% Y-o-Y for the quarter.</li>
</ul>
<h3 class="heading" id="revised-guidance-or-forecasts">
  Revised Guidance or Forecasts
  <a class="anchor" href="#revised-guidance-or-forecasts">#</a>
</h3>
<ul>
<li>Management aims for 15% margin profile across businesses in the long run.</li>
<li>Expects to finish the current year with EBITDA margins around 11-12%.</li>
<li>Hopes to improve margins in the next financial year but finds it &ldquo;premature&rdquo; to give a specific number.</li>
</ul>
<h3 class="heading" id="areas-of-growth-or-decline">
  Areas of Growth or Decline
  <a class="anchor" href="#areas-of-growth-or-decline">#</a>
</h3>
<ul>
<li><strong>Growth:</strong>
<ul>
<li>Non-GLE business (mixing, heavy engineering, solid-liquid separation).</li>
<li>Services business in India.</li>
<li>Heavy engineering business.</li>
</ul>
</li>
<li><strong>Decline/Slowdown:</strong>
<ul>
<li>GLE business (starting to recover).</li>
<li>Chemical industry, especially agrochemicals.</li>
<li>International business (showing a slowdown).</li>
</ul>
</li>
</ul>
<h2 class="heading" id="strategic-initiatives--business-updates">
  Strategic Initiatives &amp; Business Updates
  <a class="anchor" href="#strategic-initiatives--business-updates">#</a>
</h2>
<h3 class="heading" id="major-strategic-announcements">
  Major Strategic Announcements
  <a class="anchor" href="#major-strategic-announcements">#</a>
</h3>
<ul>
<li><strong>Diversification:</strong> Reducing focus on chemicals and pharma, exploring new industry segments (oil &amp; gas, petrochemicals, metals &amp; minerals, semiconductors).</li>
<li><strong>Cost Structure Rationalization:</strong>
<ul>
<li>Consolidation of glass-lined capacity in Europe and India.</li>
<li>Moved all India GLE production to the Gujarat facility from Hyderabad.</li>
<li>Rationalized UK manufacturing footprint.</li>
<li><strong>Poland Strategy:</strong> Moving manufacturing to Poland and potentially India.</li>
<li>McKinsey project ongoing in India for operational cost reduction.</li>
</ul>
</li>
<li><strong>Focus on Services:</strong> Growing the services business in India.</li>
</ul>
<h3 class="heading" id="new-products-services-or-markets-discussed">
  New Products, Services, or Markets Discussed
  <a class="anchor" href="#new-products-services-or-markets-discussed">#</a>
</h3>
<ul>
<li><strong>New Markets/Segments:</strong> Oil &amp; gas, petrochemicals, metals &amp; minerals, wastewater, paints, semiconductors.</li>
<li><strong>Services:</strong> Increased focus and organizational changes to grow this segment in India.</li>
<li><strong>Mixing Business:</strong> A key area of focus.</li>
<li><strong>Heavy Engineering:</strong> Focus on right MOCs, export orders, and specific equipment.</li>
<li><strong>Biological Space:</strong> Keeping track of developments and engaged with customers on peptides.</li>
</ul>
<h3 class="heading" id="significant-operational-changes">
  Significant Operational Changes
  <a class="anchor" href="#significant-operational-changes">#</a>
</h3>
<ul>
<li><strong>Hyderabad Facility:</strong> Production consolidated to Gujarat. Facility &ldquo;on hold&rdquo;.</li>
<li><strong>UK Manufacturing:</strong> Footprint rationalized.</li>
<li><strong>Poland Manufacturing:</strong> Investment agreement signed, initial orders successfully executed.</li>
</ul>
<h3 class="heading" id="ongoing-or-completed-projects">
  Ongoing or Completed Projects
  <a class="anchor" href="#ongoing-or-completed-projects">#</a>
</h3>
<ul>
<li><strong>Poland Facility Development:</strong> Ongoing.</li>
<li><strong>McKinsey Cost Optimization Project (India):</strong> At the final stage.</li>
<li><strong>Test Center (Karamsad, Gujarat):</strong> Inaugurated and operational.</li>
</ul>
<h2 class="heading" id="market--competitive-landscape">
  Market &amp; Competitive Landscape
  <a class="anchor" href="#market--competitive-landscape">#</a>
</h2>
<h3 class="heading" id="industry-trends">
  Industry Trends
  <a class="anchor" href="#industry-trends">#</a>
</h3>
<ul>
<li><strong>Chemical Industry:</strong> Generally slow, driven by agrochemical slowdown.</li>
<li><strong>Specialty Chemicals:</strong> Expected to continue to grow and invest.</li>
<li><strong>Pharmaceutical Industry:</strong> Generally positive, traction in South India (Hyderabad) for CDMO/export capacity.</li>
<li><strong>Cyclicality:</strong> Acknowledged in chemical and pharma markets, driving diversification.</li>
<li><strong>Manufacturing returning to the US:</strong> Mentioned as a potential driver for heavy engineering exports.</li>
</ul>
<h3 class="heading" id="competitive-positioning-statements">
  Competitive Positioning Statements
  <a class="anchor" href="#competitive-positioning-statements">#</a>
</h3>
<ul>
<li><strong>GLE in India:</strong> Do not see significant Chinese competition.</li>
<li><strong>Non-GLE:</strong> Occasional competition from China and other countries, but GMM Pfaudler is well-positioned.</li>
<li><strong>Differentiation:</strong> Aims for technical differentiation in every product line.</li>
<li><strong>Brand Reputation:</strong> GMM Pfaudler brand associated with problem-solving.</li>
</ul>
<h3 class="heading" id="market-challenges-or-opportunities-mentioned">
  Market Challenges or Opportunities Mentioned
  <a class="anchor" href="#market-challenges-or-opportunities-mentioned">#</a>
</h3>
<ul>
<li><strong>Challenges:</strong>
<ul>
<li>Slowdown in chemical (especially agrochemical) and pharmaceutical industries.</li>
<li>International business slowdown, particularly Europe.</li>
<li>Cyclical nature of core markets.</li>
</ul>
</li>
<li><strong>Opportunities:</strong>
<ul>
<li>Diversification into new industries.</li>
<li>Growth in the services business in India.</li>
<li>Export potential for heavy engineering.</li>
<li>Cost efficiencies from manufacturing footprint rationalization.</li>
<li>Market recovery in chemicals/pharma expected in a few quarters.</li>
</ul>
</li>
</ul>
<h3 class="heading" id="comments-about-market-share-or-positioning">
  Comments about Market Share or Positioning
  <a class="anchor" href="#comments-about-market-share-or-positioning">#</a>
</h3>
<ul>
<li><strong>GLE:</strong> Market share is 50%.</li>
<li><strong>New Industries:</strong> Market share is &ldquo;very, very small&rdquo;.</li>
<li><strong>Market Leader in Hyderabad (GLE).</strong></li>
</ul>
<h2 class="heading" id="risk-factors--challenges">
  Risk Factors &amp; Challenges
  <a class="anchor" href="#risk-factors--challenges">#</a>
</h2>
<h3 class="heading" id="concerns-or-challenges-acknowledged-by-management">
  Concerns or Challenges Acknowledged by Management
  <a class="anchor" href="#concerns-or-challenges-acknowledged-by-management">#</a>
</h3>
<ul>
<li><strong>Slowdown in Core Markets:</strong> Chemical (agrochemical) and pharmaceutical industry slowdown.</li>
<li><strong>Cyclicality of Markets:</strong> Over-reliance on chemical and pharma markets.</li>
<li><strong>International Business Slowdown:</strong> Europe, in particular, is experiencing a slowdown.</li>
<li><strong>Time for Recovery:</strong> Full turnaround in chemical and pharmaceutical industries might take &ldquo;a few more quarters.&rdquo;</li>
<li><strong>Execution of Diversification:</strong> Finding new opportunities in non-GLE and non-chemical/pharma industries takes time.</li>
</ul>



<div class="button-container">    
    <a href="https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c47c8f6-a227-4369-a4ad-5c1974058bea.pdf" target="_blank" class="report-button">
      <i class="fas fa-file-pdf"></i> Download Transcript
    </a>
</div>
    



    
  </div>

  


  

  
  

<div class="single-pagination">
    <hr />

    <div class="flex">

        <div class="single-pagination-prev">
            
            <div class="single-pagination-container-prev">
                <div class="single-pagination-text">←</div>
                <div class="single-pagination-text">
                    <a href="/posts/bikaji-foods-international-ltd---feb-2025-earnings-call-transcript-analysis/">
                        Bikaji Foods International Ltd - Feb 2025 Earnings Call Transcript Analysis
                    </a>
                </div>
            </div>
            
        </div>

        <div class="single-pagination-next">
            
            <div class="single-pagination-container-next">
                <div class="single-pagination-text">
                    <a href="/posts/i-g-petrochemicals-limited-q3-fy25-earnings-call2025-02-14/">
                        I G Petrochemicals Limited: Q3 FY25 Earnings Call
                    </a>
                </div>
                <div class="single-pagination-text">→</div>
            </div>
            
        </div>

    </div>

    <hr />
</div>



  <div id="disqus_thread"></div>
<script>
    

    

    (function() { 
    var d = document, s = d.createElement('script');
    s.src = 'https://muthuai.disqus.com/embed.js';
    s.setAttribute('data-timestamp', +new Date());
    (d.head || d.body).appendChild(s);
    })();
</script>
<noscript>Please enable JavaScript to view the <a href="https://disqus.com/?ref_noscript">comments powered by Disqus.</a></noscript>
  

  

  
  <div class="back-to-top">
    <a href="#top">
      back to top
    </a>
  </div>
  

</div>


    </main>
  </div>

  <footer>
    

    
    
    
    <p>Made with ♥ in India</p>
    


  </footer>

  

</body>

<script>

  function isAuto() {
    return document.body.classList.contains("auto");
  }

  function setTheme() {
    if (!isAuto()) {
      return
    }

    document.body.classList.remove("auto");
    let cls = "light";
    if (window.matchMedia && window.matchMedia('(prefers-color-scheme: dark)').matches) {
      cls = "dark";
    }

    document.body.classList.add(cls);
  }

  function invertBody() {
    document.body.classList.toggle("dark");
    document.body.classList.toggle("light");
  }

  if (isAuto()) {
    window.matchMedia('(prefers-color-scheme: dark)').addListener(invertBody);
  }

  setTheme();

</script>
<script>
    window.addEventListener('DOMContentLoaded', (event) => {
        new PagefindUI({ element: "#search", showSubResults: false, showImages: false });
    });
</script>
<script defer src="/js/copy-code.js"></script>
</html>